Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR

<p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) has been reported to downregulate E-cadherin (E-cad); however, whether the downregulation of E-cad has any effect on EGFR expression has not been elucidated. Our previous studies have found an...

Full description

Bibliographic Details
Main Authors: Shin Dong M, Zhang Hongzheng, Huang Donghai, Su Ling, Wang Dongsheng, Chen Zhuo G
Format: Article
Language:English
Published: BMC 2011-09-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/10/1/116
_version_ 1818520524215549952
author Shin Dong M
Zhang Hongzheng
Huang Donghai
Su Ling
Wang Dongsheng
Chen Zhuo G
author_facet Shin Dong M
Zhang Hongzheng
Huang Donghai
Su Ling
Wang Dongsheng
Chen Zhuo G
author_sort Shin Dong M
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) has been reported to downregulate E-cadherin (E-cad); however, whether the downregulation of E-cad has any effect on EGFR expression has not been elucidated. Our previous studies have found an inverse correlation between EGFR and E-cad expression in tissue specimens of squamous cell carcinoma of the head and neck (SCCHN). To understand the biological mechanisms underlying this clinical observation, we knocked down E-cad expression utilizing E-cad siRNA in four SCCHN cell lines.</p> <p>Results</p> <p>It was observed that downregulation of E-cad upregulated EGFR expression compared with control siRNA-transfected cells after 72 hours. Cellular membrane localization of EGFR was also increased. Consequently, downstream signaling molecules of the EGFR signaling pathway, p-AKT, and p-ERK, were increased at 72 hours after the transfection with E-cad siRNA. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed EGFR mRNA was upregulated by E-cad siRNA as early as 24 hours. In addition, RT-PCR revealed this upregulation was due to the increase of EGFR mRNA stability, but not protein stability. Sulforhodamine B (SRB) assay indicated growth of E-cad knocked down cells was enhanced up to 2-fold more than that of control siRNA-transfected cells at 72-hours post-transfection. The effect of E-cad reduction on cell proliferation was blocked by treating the E-cad siRNA-transfected cells with 1 μM of the EGFR-specific tyrosine kinase inhibitor erlotinib.</p> <p>Conclusion</p> <p>Our results suggest for the first time that reduction of E-cad results in upregulation of EGFR transcriptionally. It also suggests that loss of E-cad may induce proliferation of SCCHN by activating EGFR and its downstream signaling pathways.</p>
first_indexed 2024-12-11T01:38:39Z
format Article
id doaj.art-4fb8f1b297c04ee58cbda4fb085a2584
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-11T01:38:39Z
publishDate 2011-09-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-4fb8f1b297c04ee58cbda4fb085a25842022-12-22T01:25:07ZengBMCMolecular Cancer1476-45982011-09-0110111610.1186/1476-4598-10-116Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFRShin Dong MZhang HongzhengHuang DonghaiSu LingWang DongshengChen Zhuo G<p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) has been reported to downregulate E-cadherin (E-cad); however, whether the downregulation of E-cad has any effect on EGFR expression has not been elucidated. Our previous studies have found an inverse correlation between EGFR and E-cad expression in tissue specimens of squamous cell carcinoma of the head and neck (SCCHN). To understand the biological mechanisms underlying this clinical observation, we knocked down E-cad expression utilizing E-cad siRNA in four SCCHN cell lines.</p> <p>Results</p> <p>It was observed that downregulation of E-cad upregulated EGFR expression compared with control siRNA-transfected cells after 72 hours. Cellular membrane localization of EGFR was also increased. Consequently, downstream signaling molecules of the EGFR signaling pathway, p-AKT, and p-ERK, were increased at 72 hours after the transfection with E-cad siRNA. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed EGFR mRNA was upregulated by E-cad siRNA as early as 24 hours. In addition, RT-PCR revealed this upregulation was due to the increase of EGFR mRNA stability, but not protein stability. Sulforhodamine B (SRB) assay indicated growth of E-cad knocked down cells was enhanced up to 2-fold more than that of control siRNA-transfected cells at 72-hours post-transfection. The effect of E-cad reduction on cell proliferation was blocked by treating the E-cad siRNA-transfected cells with 1 μM of the EGFR-specific tyrosine kinase inhibitor erlotinib.</p> <p>Conclusion</p> <p>Our results suggest for the first time that reduction of E-cad results in upregulation of EGFR transcriptionally. It also suggests that loss of E-cad may induce proliferation of SCCHN by activating EGFR and its downstream signaling pathways.</p>http://www.molecular-cancer.com/content/10/1/116
spellingShingle Shin Dong M
Zhang Hongzheng
Huang Donghai
Su Ling
Wang Dongsheng
Chen Zhuo G
Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
Molecular Cancer
title Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
title_full Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
title_fullStr Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
title_full_unstemmed Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
title_short Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
title_sort downregulation of e cadherin enhances proliferation of head and neck cancer through transcriptional regulation of egfr
url http://www.molecular-cancer.com/content/10/1/116
work_keys_str_mv AT shindongm downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr
AT zhanghongzheng downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr
AT huangdonghai downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr
AT suling downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr
AT wangdongsheng downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr
AT chenzhuog downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr